CCL2 and neoplasm: Tumor associated macrophage (TAMs) are classically known to promote tumor growth and metastasis, but following treatment with IL-12, TAMs exhibit reduced production of tumor promoting factors (IL-10, MCP-1, MIF, and TGFβ) (20).